SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001725160-22-000155
Filing Date
2022-08-09
Accepted
2022-08-09 16:13:05
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zntl-20220630.htm   iXBRL 10-Q 1738878
2 EX-10.8# zentalis-executiveemployme.htm EX-10.8# 170551
3 EX-31.1 zentalis10-qq22022ex311.htm EX-31.1 10981
4 EX-31.2 zentalis10-qq22022ex312.htm EX-31.2 11231
5 EX-32.1 zentalis10-qq22022ex321.htm EX-32.1 5267
6 EX-32.2 zentalis10-qq22022ex322.htm EX-32.2 5678
12 image_0.jpg GRAPHIC 104
13 image_1.jpg GRAPHIC 134
  Complete submission text file 0001725160-22-000155.txt   6393023

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zntl-20220630.xsd EX-101.SCH 33379
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zntl-20220630_cal.xml EX-101.CAL 67791
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zntl-20220630_def.xml EX-101.DEF 148642
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zntl-20220630_lab.xml EX-101.LAB 451909
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zntl-20220630_pre.xml EX-101.PRE 297051
64 EXTRACTED XBRL INSTANCE DOCUMENT zntl-20220630_htm.xml XML 920740
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39263 | Film No.: 221148449
SIC: 2834 Pharmaceutical Preparations